Majesty Therapeutics, Inc.
New Form D on file · 2026-05-15 · the record
What the record says
Trailing twelve months. 716 filings in Biotechnology, totalled by week. The dot is this raise, $100K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Use of proceeds, as written on the filing
Proceeds of the offering will be used for research and development, trial design and regulatory filings, manufacturing, working capital and general corporate purposes and potentially for the acquisition of, or investment in, complementary businesses
Company officers on record
On the filing as: Executive Officer, Director.
Shawn Titcomb is named as Chief Executive Officer on the Form D that Majesty Therapeutics, Inc. filed with the SEC on 15 May 2026, one of 3 people that filing names.
On the filing as: Executive Officer.
Adrian Hepner is named as Acting Chief Medical Officer on the Form D that Majesty Therapeutics, Inc. filed with the SEC on 15 May 2026, one of 3 people that filing names.
On the filing as: Executive Officer.
Ankit Bhargava is named as Acting Chief Scientific Officer on the Form D that Majesty Therapeutics, Inc. filed with the SEC on 15 May 2026, one of 3 people that filing names.
3 people named on the filing — 3 holding an executive role.
Named as of the 2026-05-15 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 3 people named on the filing — 3 holding an executive role.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Majesty Therapeutics, Inc.
- Source Check — verify Shawn Titcomb's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Shawn Titcomb for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Majesty Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Majesty Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.